PharmaNet/i3 Expands Randomization and Trial Supply Management Solution


Company News Release

Princeton, NJ – June 21, 2012 – PharmaNet/i3, inVentiv Health’s clinical segment, and a provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, today announced a major new release of the PharmaNet/i3 Interactive Response Technologies (IRT) clinical trial randomization and supply management system. The new release expands capabilities by providing a wide array of configurable functionality for both the web (IWR) and telephone (IVR). Offered via a “Software as a Service” (SaaS) delivery model, this marks the third major release of the product which has been supporting active studies since 2010.

The new release enables sponsors to realize comprehensive randomization and supply management solutions for their trials using configurable, pre-validated software components. Rich configuration options and the ability to deploy solutions over the web and telephone provide maximum flexibility for supporting diverse clinical trial designs. The web interface is compatible with all popular web browsers and is designed to work well on computer screens as well as tablets such as the iPad.

PharmaNet/i3 is committed to providing custom IRT solutions to enable optimal study operating efficiencies and logistics. The latest release of PharmaNet/i3 IRT increases the use of pre-validated functionality while continuing to support study-specific customizations. This powerful combination shortens initial deployment schedules and supports rapid configuration changes should they be needed during the course of a study.

PharmaNet/i3’s highly experienced IRT project managers partner with clients and study teams to identify requirements for each study, and coordinate and guide the team to produce tailored solutions. IRT project managers remain the central contact for support throughout the study lifecycle in conjunction with the 24/7 support team.

“PharmaNet/i3 has been providing IRT solutions for nearly a decade and has delivered every study on-time without exception. Being part of a full service CRO, we understand the challenges study managers face during study startup. Knowing that they can count on a quality IRT system to be delivered within their timeline enables the manager and study team to focus their attention on the many other key start-up activities,” said Charles Gasman, Executive Director of Interactive Technologies, PharmaNet/i3.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.